No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs4499013 |
chr11:119488646-119488647 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs73578804 |
chr11:119488688-119488689 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
3 |
rs185452817 |
chr11:119488691-119488692 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs560228021 |
chr11:119488701-119488702 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs572350860 |
chr11:119488725-119488726 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs546166106 |
chr11:119488745-119488746 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs150765955 |
chr11:119488760-119488761 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs571673913 |
chr11:119488790-119488791 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs138099829 |
chr11:119488804-119488805 |
Enhancers Bivalent Enhancer Weak transcription Genic enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs549952942 |
chr11:119488811-119488812 |
Enhancers Bivalent Enhancer Weak transcription Genic enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs4354701 |
chr11:119488812-119488813 |
Enhancers Bivalent Enhancer Weak transcription Genic enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
12 |
rs529422104 |
chr11:119488912-119488913 |
Enhancers Bivalent Enhancer Weak transcription Genic enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs189475048 |
chr11:119488970-119488971 |
Enhancers Bivalent Enhancer Weak transcription Genic enhancers Flanking Active TSS Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs149527334 |
chr11:119489050-119489051 |
Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs117039624 |
chr11:119489051-119489052 |
Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs147459766 |
chr11:119489064-119489065 |
Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs180727083 |
chr11:119489091-119489092 |
Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs112930270 |
chr11:119489140-119489141 |
Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs555945768 |
chr11:119489146-119489147 |
Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs139820799 |
chr11:119489149-119489150 |
Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs115683675 |
chr11:119489177-119489178 |
Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs570719565 |
chr11:119489191-119489192 |
Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs12361680 |
chr11:119489210-119489211 |
Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs572112918 |
chr11:119489254-119489255 |
Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs545823797 |
chr11:119489355-119489356 |
Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs145347975 |
chr11:119489356-119489357 |
Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs368904640 |
chr11:119489370-119489371 |
Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs543235473 |
chr11:119489373-119489374 |
Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs186055897 |
chr11:119489406-119489407 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs529365383 |
chr11:119489498-119489499 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs147282716 |
chr11:119489538-119489539 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs372242265 |
chr11:119489566-119489567 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs559427101 |
chr11:119489602-119489603 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs79544257 |
chr11:119489607-119489608 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs551381376 |
chr11:119489655-119489656 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs140797640 |
chr11:119489656-119489657 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs142417669 |
chr11:119489779-119489780 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs572172524 |
chr11:119489811-119489812 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs574491409 |
chr11:119489812-119489813 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs138713709 |
chr11:119489814-119489815 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs371885194 |
chr11:119489820-119489821 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs201106198 |
chr11:119489828-119489829 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs202136536 |
chr11:119489829-119489830 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs113404832 |
chr11:119489903-119489904 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs11217353 |
chr11:119489905-119489906 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs372510018 |
chr11:119489979-119489980 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs567898015 |
chr11:119489984-119489985 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs11217354 |
chr11:119490006-119490007 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs188862525 |
chr11:119490084-119490085 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs556682290 |
chr11:119490086-119490087 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|